BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28752368)

  • 1. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
    Kikuchi I; Kase S; Ishijima K; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Topical Interferon Alpha-2b Eye Drop as an Adjunctive Therapy Following Surgical Resection in Ocular Surface Squamous Neoplasia.
    Kanaya R; Kase S; Ishijima K; Ishida S
    In Vivo; 2019; 33(6):2211-2215. PubMed ID: 31662558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
    Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
    Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
    Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
    Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
    Demirci H; McCormick SA; Finger PT
    Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Schechter BA; Schrier A; Nagler RS; Smith EF; Velasquez GE
    Cornea; 2002 Jan; 21(1):6-11. PubMed ID: 11805499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha for the treatment of melanocytic conjunctival lesions.
    Herold TR; Hintschich C
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):111-5. PubMed ID: 19756691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Interferon α-2b as a Single Therapy for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Sinha B; Kumar R
    Asia Pac J Ophthalmol (Phila); 2015; 4(5):279-82. PubMed ID: 26176194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma.
    Falco LA; Gruosso PJ; Skolnick K; Bejar L
    Optometry; 2007 Apr; 78(4):162-6. PubMed ID: 17400137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
    Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
    Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alfa-2b in the management of recurrent conjunctival papillomatosis.
    Singh M; Gautam N; Gupta A; Kaur M
    Indian J Ophthalmol; 2016 Oct; 64(10):778-780. PubMed ID: 27905345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.